Anita Gupta, DO, is a practicing anesthesiologist and a pioneer in the field of pain medicine. In her productive career as a physician-scientist and executive, she has built an international reputation for her clinical, policy, research and drug expertise.
Of special interest to Dr. Gupta are interventional pain management, preventive medicine, health policy, biopharmaceuticals, digital and genomics. The research that Dr. Gupta has worked on the opioid crisis and digital transformation to improve the patient experience continues to reshape the future of medicine.
Dr. Gupta’s philosophy of care is based on the belief that patients should be fully empowered with shared decision making and believes that each patient requires a specific care plan tailored to their individual needs. She uses state of the art technology and best in class innovations in advanced pain care to treat her patients and utilizes innovative therapeutics and medications when only clinically necessary.
Dr. Gupta is recognized by the American Society of Anesthesiologists, as the first appointed woman physician anesthesiologist to lead the expansion of the only opioid overdose antidote, naloxone, at the U.S. FDA appointed by leaders at the American Society of Anesthesiologists. She is also recognized as the first woman physician anesthesiologist to Co-Chair the American Society of Anesthesiologist Committee on Prescription Opioid Abuse. Dr. Gupta is also an active faculty member at Johns Hopkins School of Medicine Department of Anesthesiology and Critical Care Medicine.
In 2021, Dr. Gupta was appointed as a Distinguished Fellow of the National Academies of Practice, for her commitment to addressing global public health in pain, drug safety and policy. As an active, practicing, healthcare professional for over 20 years and she serves as a member of the National Academies of Science’s Global Forum on the transformation of the patient experience, with one of the top 50 most cited commentaries in 2020 and 2021. At the National Academies of Sciences, she has pioneered the understanding of patient experience in pain and the role of digital transformation, particularly with pain.
In 2020, she was awarded the Top 100 Inspiring Leader Award by PharmaVoice, Top 10 Emerging Leader Award by Pharmaceutical Executive, Goldman Sachs 10K Business Scholar Award, Harvard Business School GMP Ambassador and Princeton University Women’s Network Leader.
She is a recognized thought leader expert featured on Washington Post, Forbes, CNN, on emerging threats including the Coronavirus pandemic, the Opioid crisis, Zika crisis, catastrophic train crashes, and high-profile expert medical cases.
